Jump to navigation
This blog post was originally published on Impatient Optimists, by Pascal Barollier, Director of Communications at Gavi, the Vaccine Alliance.
By Stephanie Bricking, Albert B. Sabin Archivist, University of Cincinnati
In partnership with the Fraunhofer Center for Molecular Biotechnology and the Walter Reid Army Institute for Research, the Sabin Vaccine Institute has successfully expressed the hookworm-derived antigen Na-APR-1.
A new study asserts that a particular type of schistosomiasis may predispose women to contracting HIV.
The Sabin Sustainable Immunization Financing (SIF) Program was on the agenda at a symposium hosted by the Penn Center for Vaccine Ethics and Policy.